Zai Lab (US) LLC
1440 O’Brien Drive
About Zai Lab (US) LLC
Zai Lab is an innovative commercial stage biopharmaceutical company focused on bringing transformative medicines for cancer, infectious and autoimmune diseases to patients in China and around the world. To quickly target the large, fast-growing segments of China’s pharmaceutical market and address unmet medical needs, Zai Lab’s experienced team has secured partnerships with leading global biopharma companies, generating a broad pipeline of innovative drug candidates. Zai Lab has also built an in-house team with strong drug discovery and translational research capabilities, aiming to establish a global pipeline of proprietary drug candidates against targets in our focus areas. Zai Lab’s vision is to become a fully integrated biopharmaceutical company, discovering, developing, manufacturing and commercializing its portfolio in order to impact human health worldwide.
For additional information about the company, please visit www.zailaboratory.com.
Stock Symbol: ZLAB
Stock Exchange: NYSE
2 articles with Zai Lab (US) LLC
Here’s a run-down of some of the most recent collaboration announcements this week.
12/4/2020Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.